CTSI Update
BU CTSI Application/Expression of Interest Deadline: Sep. 13, 2021
Sponsor (CTSA/NCATS) Application Deadline: Nov. 1, 2021

The BU CTSI seeks to submit to the NIH two diversity supplements to our current Clinical and Translational Science Institute award. The goal of these supplements is to build a diverse clinical and translational research workforce that is prepared to improve the quality, safety, efficiency, and speed of clinical and translational science research nationally. See Full RFA
Now in its fifth year, the BU CTSI PRIME: Pathways to Research Independence and Mentoring Excellence Program provides an opportunity for K Grant Awardees to receive both mentored and independent research support to transition to independent funding. Read More
Reminder
The BU CTSI Pilot Grant Program helps investigators explore and solve major challenges in translational science, especially those that address the special health problems of our urban communities, by developing and deploying new tools, methods, and processes to expedite clinical and translational research and discovery. Learn More
An Interactive Seminar Series for Postdoctoral Fellows and Early Career Faculty (formerly the CREST Program)
Want to learn how to write an effective abstract and paper? Get familiar with qualitative methods? Give a professional talk? How to position yourself to write a career development award? Ways to use social media to promote your research activities? Then this Seminar Series is for you. Learn More
Challenge & Funding Opportunities

Notice of Special Interest (NOSI): International Research Collaboration on Drug Abuse and Addiction Research

National Institute on Drug Abuse (NIDA)

American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional)

National Institute of Allergy and Infectious Diseases (NIAID)

Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed)

National Institute of Dental and Craniofacial Research (NIDCR)

Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed)

National Institute of Neurological Disorders and Stroke (NINDS)

High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 - Clinical Trial Not Allowed)

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required)

National Institute on Aging (NIA)

Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed)

National Institute of Environmental Health Sciences (NIEHS)

Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)

National Institute on Drug Abuse (NIDA)
AHA/CHF Congenital Heart Defect Research Awards
Application Due Date: September 23, 2021

The purpose of the CHDRAs is to provide support for investigators who are actively conducting research directly related to advancing the prevention, diagnosis, and treatment of CHDs. The joint RFA and funding opportunity will further this goal by offering competitive research grants in basic, clinical, population, or translational research related to CHDs. Read More
News Highlights
NIH Launches Study of Third COVID-19 Vaccine Dose in Kidney Transplant Recipients

A pilot study has begun to assess the antibody response to the third dose of COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine. Read More

NIH Hamster Study Evaluates Airborne and Fomite Transmission of SARS-CoV-2

To investigate how different routes of exposure affected disease development, the scientists exposed hamsters to SARS-CoV-2 via both aerosols and fomites. Read More
SARS-CoV-2 Antibody Magnitude and Detectability are Driven by Disease Severity, Timing, and Assay

This study documents the large heterogeneity in longitudinal antibody responses to SARS-CoV-2 across a large number of commercial and research assays in a diverse cohort of individuals. Read More
Upcoming Course & Events
Live, Interactive Webcast!
Aug. 19, 2021, 7:30 - 9 p.m.

This Oncology Consultations® is a live webcast in which two experts, using a case-based approach, discuss current and emerging therapeutic strategies for triple-negative breast cancer. Read More
Application due: Aug. 20, 2021
(CTSA member: $375.00)

This course offers an overview of the concepts of clinical/translational research through the dynamic and interactive medium of online learning. Read More
Technical Assistance Webinar for
Clinical and Translational Science Award (UM1) (PAR-21-293)
Sep. 28, 2021, 1 - 3 p.m.

NCATS is conducting a technical assistance webinar for applicants responding
to the Clinical and Translational Science Award (UM1 Clinical Trial Optional)
The Funding Acknowledgement
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.